Abstract:Frankincense and myrrha (FM), commonly used as a classical herbal pair, have a wide range of clinical applications and definite anti-inflammatory activity. However, anti-neuroinflammation effects and mechanisms are not clear. In this study, we adopted a lipopolysaccharide (LPS)-induced microglial (BV2) cell model and a network pharmacology method to reveal the anti-neuroinflammatory effects and mechanisms of boswellic acid (BA) and myrrha sesquiterpenes (MS) with different proportions of compatibility. The data showed that the different ratios of BA and MS had different degrees of inhibition of interleukin-1β (IL-1β), IL-6, and inducible nitric oxide synthase (iNOS) mRNA expression, down-regulated the phosphor-nuclear factor kappa B/nuclear factor kappa B (p-NF-ҡB)/(NF-ҡB), phosphorylated protein kinase b/protein kinase b (p-AKT/AKT), and Toll-like receptor 4 (TLR4) protein expression levels, and increased phospho-PI3 kinase (p-PI3K) protein expression levels. When the ratios of BA and MS were 10:1, 5:1, and 20:1, better effective efficacy was exhibited. According to the correlation analysis between the effect index and bioactive substances, it was suggested that 2-methoxy-5-acetoxy -fruranogermacr-1(10)-en-6-one (Compound 1), 3α-acetyloxylanosta-8,24-dien-21-oic acid (Compound 2), 11-keto-boswellic acid (Compound 3), and 3-acetyl-11-keto-β -boswellic acid (Compound 4) made important contributions to the treatment of neuroinflammation. Furthermore, based on the network pharmacological analysis, it was found that these four active compounds acted on 31 targets related to neuroinflammation and were involved in 32 signaling pathways which mainly related to the immune system, cardiovascular system, and nervous system, suggesting that BA and MS could be used to treat neuroinflammation.

Sesquiterpenes Inhibiting the Microglial Activation from Laurus Nobilis

Potential inhibitors of microglial activation from the roots of<i> Vernicia</i> montana Lour

Potential inhibitors of microglial activation from the roots of Vernicia montana Lour

Further terpenoids from the Chloranthaceae plant Chloranthus multistachys and their anti-neuroinflammatory activities

Sesquiterpenoids from Chloranthus Henryi and Their Anti‐neuroinflammatory Activities

Activity-guided isolation and identification of antiherpesvirus and antineuroinflammatory active terpenoids from Artemisia vulgaris L. based on the LC-MS/MS molecular network

Potential inhibitors of microglial activation from the roots of<i> Wikstroemia lichiangensis</i> W. W. Sm

Isolation and identification of cytotoxic compounds from Bay leaf (Laurus nobilis)

Meroterpenoids and Sesquiterpene Dimers from Sarcandra Glabra with Anti-Neuroinflammatory Activity

Lindenane sesquiterpenoid dimers from Chloranthus holostegius with anti-neuroinflammatory activities in BV-2 microglia

Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology

Anti-inflammatory and PTP1B inhibitory sesquiterpenoids from the twigs and leaves of <i>Aglaia lawii</i>

Bioactive sesquiterpene coumarins from the resin of Ferula sinkiangensis targeted on over-activation of microglia

Labdane diterpenoids from Lagopsis supina and their anti-neuroinflammatory activity

Terpenoids from Daphne Aurantiaca and Their Potential Anti-inflammatory Activity

Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways

GABase and glutaminase inhibitory activities of herbal extracts and acylated flavonol monoglycosides isolated from the leaves of Laurus nobilis L.

Inhibitory Effects of Sesquiterpenes from Saussurea Lappa on the Overproduction of Nitric Oxide and TNF-α Release in LPS-activated Macrophages

A New Anti-Neuroinflammation Labdane Diterpenoid from Salvia Tricuspis.

Chemical Constituents from the Roots and Stems of Litsea Cubeba

Constituents from Scutellaria barbata Inhibiting Nitric Oxide Production in LPS-Stimulated Microglial Cells